Lupus-prone mice deficient in TLR7 exhibited an amelioration of the disease including a decrease in serum autoantibody production (e.g., anti-Sm/RNP autoantibody), negative regulation of lymphocyte activation, and reduced severity of lupus nephritis [37]. Here, TLR7 is linked to systemic lupus erythematosus.